K 56 PILL – IDENTIFICATION, DOSAGE, SIDE EFFECTS

The pink tablet imprinted with “K 56” is an immediate-release prescription formulation of Oxycodone Hydrochloride 10 mg. Manufactured by KVK Tech, Inc., it is a potent Schedule II semi-synthetic opioid analgesic used to manage moderate to severe acute or chronic pain when non-opioid alternatives are inadequate.

Pill Identification

Physical Property – Specification

• Active Ingredient – Oxycodone Hydrochloride (10 mg)
• Imprint Code – K 56 (scored across K and 56 on obverse side)
• Color – Pink
• Shape – Round
• Manufacturer – KVK Tech, Inc.
• Drug Class – Opioid Agonist (Narcotic Analgesic)
• Controlled Status – DEA Schedule II Controlled Substance

Mechanism of Action

Oxycodone acts as a full agonist primarily at the mu-opioid receptors within the central nervous system (CNS) and peripheral tissues:

• Receptor Activation: Upon binding to opioid receptors on pre- and post-synaptic neuronal membranes, oxycodone inhibits adenylate cyclase and stimulates potassium conductance while inhibiting calcium channel opening.
• Signal Blockade: This hyperpolarizes the neuronal cell membrane, inhibiting the presynaptic release of excitatory neurotransmitters (such as Substance P and glutamate).
• Altered Pain Perception: By blocking pain signal transmission along the ascending spinal pathway to the brain, oxycodone reduces the sensation of physical pain. It simultaneously acts on the brain’s limbic system to alter the emotional perception of pain.

Pharmacokinetics & Dosage

Onset and Duration

• Onset of Action: 15 to 30 minutes after oral ingestion.
• Peak Effect: 1 to 2 hours.
• Duration of Pain Relief: 3 to 6 hours.
• Elimination Half-Life: Approximately 3.5 to 4 hours.

Dosing Guidelines

• Initial Dosage: Typically 5 mg to 15 mg every 4 to 6 hours as needed for pain. A single K 56 tablet provides a 10 mg dose.
• Individualization: Dosing must be titrated by a healthcare provider based on the patient’s pain severity, previous opioid tolerance, and therapeutic response.
• Administration: May be taken with or without food; taking it with food can help diminish initial gastrointestinal discomfort.

Side Effects

Common Side Effects

• Gastrointestinal: Constipation, nausea, vomiting, dry mouth.
• Central Nervous System: Drowsiness, dizziness, lightheadedness, headache, sedation.
• Dermatologic: Pruritus (itching), flushing, or mild diaphoresis (sweating).

Serious Adverse Reactions

• Severe Respiratory Depression: Abnormally slow, shallow, or difficult breathing.
• Hypotension: Significant drop in blood pressure, leading to fainting (syncope) or severe dizziness.
• Serotonin Syndrome: High fever, agitation, muscle rigidity, and tremors when combined with serotonergic drugs.
• Adrenal Insufficiency: Fatigue, anorexia, hypotension, and nausea after prolonged use.

Boxed Warnings & Safety Precautions

FDA Black Box Warnings

• Addiction, Abuse, and Misuse: Oxycodone carries a high risk of opioid addiction, abuse, and misuse, which can lead to overdose and death. Assess each patient’s risk prior to prescribing.
• Life-Threatening Respiratory Depression: Serious, life-threatening, or fatal respiratory depression may occur, particularly during initiation or following a dose increase.
• Accidental Ingestion: Accidental ingestion of even one dose, especially by children, can result in a fatal overdose of oxycodone.
• Concomitant Use with Benzodiazepines: Concomitant use of opioids with benzodiazepines, central nervous system (CNS) depressants, or alcohol may result in profound sedation, respiratory depression, coma, and death.
• Neonatal Opioid Withdrawal Syndrome (NOWS): Prolonged use of oxycodone during pregnancy can result in life-threatening neonatal withdrawal. >

Precautions

• Tolerance and Physical Dependence: Rapid physical dependence can develop with regular use. Never stop taking this medication abruptly after long-term use; a gradual tapering schedule is required to avoid severe withdrawal symptoms.
• Counterfeit Alert: Due to high illicit demand, counterfeit K 56 pills containing illegal synthetic opioids (such as lethal doses of fentanyl) are widespread in illicit distribution channels. Only obtain medications directly from licensed pharmacies.

Drug Interactions & Overdose Management

Critical Drug Interactions

• CNS Depressants & Alcohol: Alcohol, sedatives, hypnotics, tranquilizers, and other opioids dangerously amplify respiratory depression and CNS sedation.
• MAO Inhibitors: Concomitant use or use within 14 days of Monoamine Oxidase Inhibitors (MAOIs) can precipitate severe serotonin syndrome or cardiovascular instability.
• CYP3A4 & CYP2D6 Inhibitors/Inducers: Drugs like ketoconazole, erythromycin, or ritonavir can increase oxycodone plasma concentrations, raising overdose risks.

Overdose Signs & Treatment

• Triad of Opioid Toxicity: Pinpoint pupils (miosis), respiratory depression (slow/stopped breathing), and unresponsiveness or coma.
• Emergency Treatment: Opioid overdose requires immediate emergency medical services (911) and the prompt administration of Naloxone (Narcan), an opioid antagonist that displaces oxycodone from opioid receptors to restore breathing.